+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Hearing recovery in sudden deafness patients using a modified defibrinogenation therapy

Hearing recovery in sudden deafness patients using a modified defibrinogenation therapy

Acta Oto-Laryngologica. Supplementum 501: 46-50

Ninety-eight patients with idiopathic sudden deafness were treated with a modified defibrinogenation (DF) therapy including batroxobin, low molecular dextran, vasodilators and vitamins. Hearing improvement was evaluated with two methods: categorical judgement and improvement rate (%). By categorical judgement, 60 patients (61% of the total) were classified into recovery or good improvement categories. The improvement rate was calculated for each of the 93 patients, and the average value was 64%. Modified DF therapy was effective especially for patients with severe hearing loss of 70-90 dB with flat audiogram. Although serum fibrinogen significantly decreased after batroxobin administration there was no correlation between the concentration of fibrinogen and hearing recovery. When prognostic factors were studied, the interval between the onset of hearing loss and start of treatment, initial hearing level, and the existence of vertigo all had significant correlation with the degree of hearing recovery.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 043234082

Download citation: RISBibTeXText

PMID: 7680521

DOI: 10.3109/00016489309126213

Related references

Chronological study of recovery of sudden deafness treated with defibrinogenation and steroid therapies. Acta Oto-Laryngologica 111(5): 867-871, 1991

Anticochlear antibodies titles measured by Western-blot and hearing recovery level after corticoid therapy in patients with sudden deafness. Acta Otorrinolaringologica Espanola 55(10): 463-469, 2004

Hearing recovery and vestibular symptoms in patients with sudden deafness and profound hearing loss. Acta Oto-Laryngologica. Supplementum 514: 41-44, 1994

Hearing Recovery by Local IGF1 Therapy in Sudden Deafness. Otolaryngology - Head and Neck Surgery 145(2 Suppl.): P214-P215, 2011

Evaluation of hearing recovery in patients with sudden deafness. Acta Oto-Laryngologica. Supplementum 514: 37-40, 1994

Effects of defibrinogenation therapy on idiopathic sudden hearing loss. Otologia Fukuoka 31(6): 1231-1236, 1985

Prognostic predictors of sudden sensorineural hearing loss in defibrinogenation therapy. Acta Oto-Laryngologica 136(3): 271-276, 2016

Defibrinogenation therapy for idiopathic sudden sensorineural hearing loss in comparison with high-dose steroid therapy. Acta Oto-Laryngologica 123(1): 46-50, 2003

Hearing recovery in sudden deafness with profound hearing loss. Nihon Jibiinkoka Gakkai Kaiho 101(6): 836-840, 1998

Hearing improvement after therapy for hyperlipidemia in patients with chronic-phase sudden deafness. Annals of Otology Rhinology and Laryngology 110(2): 105-108, 2001

Efficacy of defibrinogenation and steroid therapies on sudden deafness. Archives of Otolaryngology--Head & Neck Surgery 114(6): 649-652, 1988

Prognostic factors in hearing recovery following sudden unilateral deafness. Hno 51(4): 305-309, 2003

Hearing recovery and its process from the time of onset in sudden deafness. Acta Oto-Laryngologica. Supplementum 524: 36-38, 1996

The effect of hyperbaric oxygen therapy to different degree of hearing loss and types of threshold curve in sudden deafness patients. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 24(19): 890-894, 2010

Prediction of hearing recovery in sudden deafness treated with intratympanic steroids. Acta Otorhinolaryngologica Italica 38(5): 453-459, 2018